tiprankstipranks
Inovio Pharmaceuticals (INO)
NASDAQ:INO
Holding INO?
Track your performance easily

Inovio Pharmaceuticals (INO) Financial Statements

5,734 Followers

Inovio Pharmaceuticals Financial Overview

Inovio Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-4.484; its P/E ratio is -0.91; Inovio Pharmaceuticals is scheduled to report earnings on March 4, 2025, and the estimated EPS forecast is $-0.92. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue-$ 100.76K-$ 102.65K$ 388.45K
Gross Profit-$ 100.76K-$ 102.65K$ 388.45K
EBIT$ -25.17M$ -32.24M$ -30.17M$ -24.72M$ -33.62M
EBITDA$ -24.40M$ -31.41M$ -29.41M$ -24.55M$ -32.58M
Net Income Common Stockholders$ -25.17M$ -31.90M$ -30.50M$ -25.05M$ -33.93M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 84.80M$ 110.42M$ 105.61M$ 145.29M$ 167.47M
Total Assets$ 107.06M$ 133.80M$ 129.11M$ 170.95M$ 193.10M
Total Debt$ 12.45M$ 12.98M$ 13.43M$ 30.21M$ 29.80M
Net Debt$ -72.36M$ -97.44M$ -92.19M$ -115.08M$ -137.67M
Total Liabilities$ 33.52M$ 18.50M$ 34.67M$ 53.60M$ 54.94M
Stockholders Equity$ 73.54M$ 96.74M$ 94.44M$ 117.35M$ 138.16M
Cash Flow-
Free Cash Flow$ -27.44M$ -28.66M$ -28.80M$ -26.28M$ -29.11M
Operating Cash Flow$ -27.44M$ -28.21M$ -28.76M$ -26.28M$ -29.11M
Investing Cash Flow$ 14.08M$ 9.97M$ 45.38M$ 19.94M$ -5.49M
Financing Cash Flow$ 660.65K$ 33.03M$ -11.36M$ 1.84M$ 698.63K
Currency in USD

Inovio Pharmaceuticals Earnings and Revenue History

Inovio Pharmaceuticals Debt to Assets

Inovio Pharmaceuticals Cash Flow

Inovio Pharmaceuticals Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis